53,862 Shares in Stem, Inc. (NYSE:STEM) Bought by SG Americas Securities LLC

SG Americas Securities LLC purchased a new position in shares of Stem, Inc. (NYSE:STEMFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,862 shares of the company’s stock, valued at approximately $209,000.

A number of other hedge funds have also bought and sold shares of STEM. Quadrature Capital Ltd raised its stake in shares of Stem by 289.5% in the third quarter. Quadrature Capital Ltd now owns 51,895 shares of the company’s stock valued at $220,000 after buying an additional 38,570 shares during the period. Lido Advisors LLC purchased a new position in shares of Stem during the 3rd quarter valued at $4,561,000. DNB Asset Management AS lifted its position in shares of Stem by 63.7% during the 4th quarter. DNB Asset Management AS now owns 126,568 shares of the company’s stock valued at $491,000 after buying an additional 49,256 shares during the last quarter. Deutsche Bank AG lifted its position in shares of Stem by 3.8% during the 3rd quarter. Deutsche Bank AG now owns 605,722 shares of the company’s stock valued at $2,568,000 after buying an additional 22,222 shares during the last quarter. Finally, Rock Point Advisors LLC lifted its position in shares of Stem by 39.4% during the 3rd quarter. Rock Point Advisors LLC now owns 687,445 shares of the company’s stock valued at $2,915,000 after buying an additional 194,335 shares during the last quarter. 61.63% of the stock is currently owned by institutional investors.

Stem Price Performance

Shares of NYSE STEM opened at $1.76 on Friday. The firm has a market capitalization of $277.68 million, a P/E ratio of -1.38 and a beta of 1.88. The company has a quick ratio of 1.78, a current ratio of 1.88 and a debt-to-equity ratio of 1.23. The stock’s 50-day simple moving average is $2.39 and its two-hundred day simple moving average is $3.07. Stem, Inc. has a twelve month low of $1.73 and a twelve month high of $7.79.

Stem (NYSE:STEMGet Free Report) last announced its earnings results on Wednesday, February 28th. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.09). The business had revenue of $167.42 million during the quarter, compared to the consensus estimate of $254.23 million. Stem had a negative return on equity of 27.71% and a negative net margin of 30.42%. As a group, equities analysts anticipate that Stem, Inc. will post -0.48 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on STEM shares. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $2.50 price target (down previously from $5.50) on shares of Stem in a research report on Friday, March 22nd. Piper Sandler dropped their price target on Stem from $3.00 to $2.00 and set a “neutral” rating on the stock in a research report on Thursday. TD Cowen dropped their price target on Stem from $7.00 to $5.00 and set an “outperform” rating on the stock in a research report on Thursday, February 29th. BMO Capital Markets dropped their price target on Stem from $4.00 to $3.25 and set a “market perform” rating on the stock in a research report on Thursday, February 29th. Finally, Susquehanna dropped their price objective on Stem from $5.50 to $4.00 and set a “positive” rating on the stock in a report on Thursday, February 29th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $5.96.

Check Out Our Latest Stock Report on Stem

Insiders Place Their Bets

In other Stem news, Director David S. Buzby bought 33,800 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were acquired at an average cost of $1.81 per share, for a total transaction of $61,178.00. Following the purchase, the director now directly owns 768,448 shares of the company’s stock, valued at $1,390,890.88. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. In other Stem news, Director David S. Buzby bought 33,800 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were acquired at an average cost of $1.81 per share, for a total transaction of $61,178.00. Following the purchase, the director now directly owns 768,448 shares of the company’s stock, valued at $1,390,890.88. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Saul R. Laureles sold 10,959 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $3.17, for a total value of $34,740.03. Following the transaction, the insider now owns 80,003 shares in the company, valued at $253,609.51. The disclosure for this sale can be found here. In the last ninety days, insiders have acquired 130,418 shares of company stock worth $238,045 and have sold 519,260 shares worth $1,197,289. Corporate insiders own 9.12% of the company’s stock.

About Stem

(Free Report)

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Featured Stories

Want to see what other hedge funds are holding STEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stem, Inc. (NYSE:STEMFree Report).

Institutional Ownership by Quarter for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.